Cerevel Therapeutics

The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Flag link:
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
CNBC
Google
Google Cloud
artificial intelligence
drug discovery
precision medicine
Pfizer
Colossal Biosciences
Cerevel Therapeutics
Flag link:
Cerevel to change up CEO as 7 data readouts near showdown
Cerevel to change up CEO as 7 data readouts near showdown
Fierce Biotech
Cerevel Therapeutics
Pharma CEOs
Tony Coles
Neurosciences
clinical trials
Flag link:
IPOs vs SPACs
IPOs vs SPACs
EP Vantage
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
Flag link:
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
Flag link:
How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon
How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon
Fierce Biotech
Agios Pharmaceuticals
Cerevel Therapeutics
JPMHC 2023
layoffs
Flag link:
Pfizer's neuroscience spinout scores in schizophrenia
Pfizer's neuroscience spinout scores in schizophrenia
BioPharma Dive
Cerevel Therapeutics
Pfizer
schizophrenia
clinical trials
Flag link:
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
BioSpace
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Bain Capital
Novaquest
Flag link:
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ
Flag link:
Pfizer spinoff Cerevel to raise $445M in merger with blank-check company
Pfizer spinoff Cerevel to raise $445M in merger with blank-check company
BioPharma Dive
Cerevel Therapeutics
Pfizer
M&A
SPAC
special purpose acquisition company
Flag link:
Cerevel plots first late-stage move as Pfizer drug comes through in PhII Parkinson's trial
Cerevel plots first late-stage move as Pfizer drug comes through in PhII Parkinson's trial
Endpoints
Cerevel Therapeutics
Pfizer
clinical trials
Parkinson's Disease
tavapadon
Flag link:
Pfizer spinout Cerevel hires Coles as CEO
Pfizer spinout Cerevel hires Coles as CEO
Fierce Biotech
Tony Coles
Cerevel Therapeutics
Pfizer
Pharma CEOs
Neuroscience
Flag link:
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Cerevel Therapeutics
Pfizer
Otsuka
CMOs
Parkinson's Disease
epilepsy
Flag link:
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
CP Wire
Bain Capital
Pfizer
Cerevel Therapeutics
CNS
Flag link:
Bain Capital and Pfizer Create New Company Focused on CNS Disorders
Pfizer
Bain Capital
Cerevel Therapeutics
Flag link: